# OnCo record adenoid-cystic-carcinoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/adenoid-cystic-carcinoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "adenoid-cystic-carcinoma" ;
  schema:name "Adenoid cystic carcinoma"@en ;
  schema:alternateName "ACC"@en, "Cylindroma (historical)"@en, "Adenoid cystic carcinoma of the salivary glands"@en ;
  schema:description "Adenoid cystic carcinoma is a slow-growing cancer of the salivary glands that spreads along nerves and can come back years after treatment, often in the lungs. Surgery with radiotherapy is the treatment that cures it, chemotherapy has little effect, and the tablets lenvatinib and axitinib can hold spreading disease still for months rather than shrink it."@en ;
  schema:url <https://onco.cc/cancers/adenoid-cystic-carcinoma/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Adenoid_cystic_carcinoma> ;
  schema:citation <https://en.wikipedia.org/wiki/Adenoid_cystic_carcinoma> ;
  onco:tag "subtype-page", "head-and-neck" ;
  onco:related <https://onco.cc/cancers/mucoepidermoid-carcinoma/>, <https://onco.cc/cancers/salivary-duct-carcinoma/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-tchekmedyian-lenvatinib-adenoid-cystic-jco-2019/>, <https://onco.cc/key-papers/paper-persson-myb-nfib-pnas-2009/>, <https://onco.cc/key-papers/paper-laurie-licitra-salivary-systemic-jco-2006/> ;
  onco:pipeline <https://onco.cc/drugs/rem-422/>, <https://onco.cc/trials/nct06118086/>, <https://onco.cc/trials/nct06781567/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/axitinib/>, <https://onco.cc/technologies/carbon-ion/> ;
  onco:standardOfCare <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/carbon-ion/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/sbrt/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/axitinib/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/rem-422/>, <https://onco.cc/trials/nct06118086/>, <https://onco.cc/trials/nct06781567/> .